Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit
- PMID:18494460
- DOI: 10.1021/jm800379d
Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit
Abstract
The oxazolidinone antibacterials target the 50S subunit of prokaryotic ribosomes. To gain insight into their mechanism of action, the crystal structure of the canonical oxazolidinone, linezolid, has been determined bound to the Haloarcula marismortui 50S subunit. Linezolid binds the 50S A-site, near the catalytic center, which suggests that inhibition involves competition with incoming A-site substrates. These results provide a structural basis for the discovery of improved oxazolidinones active against emerging drug-resistant clinical strains.
Similar articles
- Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells.Champney WS, Miller M.Champney WS, et al.Curr Microbiol. 2002 May;44(5):350-6. doi: 10.1007/s00284-001-0023-7.Curr Microbiol. 2002.PMID:11927986
- On the specificity of antibiotics targeting the large ribosomal subunit.Wilson DN.Wilson DN.Ann N Y Acad Sci. 2011 Dec;1241:1-16. doi: 10.1111/j.1749-6632.2011.06192.x.Ann N Y Acad Sci. 2011.PMID:22191523Review.
- Theoretical study of the interaction between the antibiotic linezolid and the active site of the 50S ribosomal subunit of the bacterium Haloarcula marismortui.Grandini GS, Morgon NH, de Souza AR.Grandini GS, et al.Chirality. 2024 Feb;36(2):e23629. doi: 10.1002/chir.23629. Epub 2023 Nov 14.Chirality. 2024.PMID:37961817
- The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, Gadwood RC, Shinabarger D, Xiong L, Mankin AS.Leach KL, et al.Mol Cell. 2007 May 11;26(3):393-402. doi: 10.1016/j.molcel.2007.04.005.Mol Cell. 2007.PMID:17499045
- On the structural basis of peptide-bond formation and antibiotic resistance from atomic structures of the large ribosomal subunit.Steitz TA.Steitz TA.FEBS Lett. 2005 Feb 7;579(4):955-8. doi: 10.1016/j.febslet.2004.11.053.FEBS Lett. 2005.PMID:15680981Review.
Cited by
- Linezolid for treatment of chronic extensively drug-resistant tuberculosis.Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd.Lee M, et al.N Engl J Med. 2012 Oct 18;367(16):1508-18. doi: 10.1056/NEJMoa1201964.N Engl J Med. 2012.PMID:23075177Free PMC article.Clinical Trial.
- Structure of the mitoribosomal small subunit with streptomycin reveals Fe-S clusters and physiological molecules.Itoh Y, Singh V, Khawaja A, Naschberger A, Nguyen MD, Rorbach J, Amunts A.Itoh Y, et al.Elife. 2022 Dec 8;11:e77460. doi: 10.7554/eLife.77460.Elife. 2022.PMID:36480258Free PMC article.
- Strategies to Improve the Potency of Oxazolidinones towards Bacterial Biofilms.Ndukwe ARN, Wiedbrauk S, Boase NRB, Fairfull-Smith KE.Ndukwe ARN, et al.Chem Asian J. 2022 Jun 1;17(11):e202200201. doi: 10.1002/asia.202200201. Epub 2022 Apr 13.Chem Asian J. 2022.PMID:35352479Free PMC article.Review.
- In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.Shaw KJ, Poppe S, Schaadt R, Brown-Driver V, Finn J, Pillar CM, Shinabarger D, Zurenko G.Shaw KJ, et al.Antimicrob Agents Chemother. 2008 Dec;52(12):4442-7. doi: 10.1128/AAC.00859-08. Epub 2008 Oct 6.Antimicrob Agents Chemother. 2008.PMID:18838596Free PMC article.
- Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study.Morgon NH, Grandini GS, Yoguim MI, Porto CM, Santana LC, Biswas S, de Souza AR.Morgon NH, et al.J Mol Model. 2021 Jul 8;27(8):222. doi: 10.1007/s00894-021-04828-8.J Mol Model. 2021.PMID:34236527Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical